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Assess Information Resources on
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ABSTRACT
Background: As patients share in the decision-making process regarding treatments they receive, it is impor-
tant that they can discriminate between reliable and unreliable sources of information about potential treat-
ments.
Methods: In this study, health professionals and patients were asked to assess the reliability of information
contained in pamphlets on treatments for asthma and atopic dermatitis using a new Japanese translation of an
instrument called DISCERN. The scores given by both groups were analyzed to assess inter-rater agreement.
The same DISCERN instrument was used by health professionals to evaluate websites on treatments for
atopic dermatitis and the degree of inter-rater agreement was assessed again.
Results: There was a greater inter-rater agreement between health professionals than between patients.
When health professionals used the instrument to evaluate websites, the final rankings given were consistent
between different raters, showing good inter-rater agreement.
Conclusions:We conclude that DISCERN is useful for evaluating the reliability of medical information both in
pamphlets and on the internet, although it is used more effectively by health professionals than by patients.
Further studies are needed on the use of DISCERN by patients in evaluating websites containing medical infor-
mation.
KEY WORDS
evaluation studies, internet, medical informatics, pamphlets, patients
INTRODUCTION
As joint decision-making between patients and doc-
tors becomes an established part of modern medical
care, there is an increasing need for patients to re-
ceive good quality information upon which to base
their decisions. However, doctors have a tendency to
underestimate both the amount of information that
patients want to receive and the amount that they are
able to process.1 Instead of relying on doctors to sat-
isfy their thirst for medical information, patients are
increasingly turning to the Internet.
In recent years the uncontrolled explosion of infor-
mation available on the Internet has led to concerns
regarding its reliability.2 Various solutions have been
proposed, including evaluation of web-based informa-
tion by doctors,3,4 electronic filtering of web-based in-
formation,5 production of reliable websites by doctors
and the creation of an ethical code of conduct for
providers of web-based medical information.6
One other approach has been to design instru-
ments to help patients themselves to rate the reliabil-
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ity and usefulness of the information they find on the
Internet and from other sources, with the ultimate
aim of patients locating and using good quality infor-
mation. These instruments have received much criti-
cism, mainly because they have not been properly
validated.4,7 Validation of the instruments presents a
difficult problem, since it necessitates the comparison
of the instruments with a current ‘gold standard’. Ow-
ing to the subjectivity of rating information quality, no
such gold standard exists. A number of ‘consensus
criteria’―specific assessment criteria which an in-
strument must include if it is to rate a website effec-
tively―have been proposed,8,9 but these have been
criticized for their lack of detail.10
DISCERN is an instrument designed to help pa-
tients assess the reliability of written information on
treatment choices11 and which has attracted consider-
able interest since its conception. During its develop-
ment and also in a number of subsequent studies,
DISCERN has shown good inter-rater agreement
when used by health professionals.12-15 However,
inter-rater agreement was lower when used by pa-
tients during DISCERN’s initial development, and all
raters in subsequent studies have been health profes-
sionals. There is little data available on how reliable
DISCERN performs when used by patients and car-
ers. DISCERN has been well received by experts in
the field of web-based medical information provision,
although some feel that the instrument has not been
fully validated.16 A web-based version of DISCERN is
available.17,18
We created a Japanese version of DISCERN to be
used by Japanese patients to evaluate Japanese lan-
guage information on medical treatments. We then
asked health professionals and carers of paediatric
patients to use this instrument to evaluate written in-
formation on treatments for asthma and atopic der-
matitis. In addition, we asked health professionals to
use the instrument to evaluate Japanese language
websites on treatments for atopic dermatitis. Our
aims were: to gather more data on inter-user agree-
ment when DISCERN is used by both health profes-
sionals and patients; to examine whether or not DIS-
CERN is useful in enabling patients to evaluate the
reliability of treatment information; and to examine
the use of DISCERN in assessing the reliability of
web-based information on atopic dermatitis.
METHODS
TRANSLATION OF THE DISCERN INSTRUMENT
The DISCERN instrument was initially translated
from English into Japanese by a native Japanese
speaker. The Japanese version was then back- trans-
lated into English by a native English speaker with-
out reference to the original version. Any inconsisten-
cies between the resulting English version and the
original version were examined and the Japanese ver-
sion adjusted appropriately. A further back-
translation from Japanese to English confirmed that
these inconsistencies had been resolved.
EVALUATION OF WRITTEN INFORMATION ON
ASTHMA AND ATOPIC DERMATITIS
Fifteen members of the medical staff and nine carers
of nine children attending the Department of Allergy
outpatient clinic at the National Centre for Child
Health and Development were each given two
pamphlets-one on asthma treatments and one on
atopic dermatitis treatments. Participants were also
provided with the Japanese version of DISCERN and
instructions on how to use it, which were based upon
the instructions given on the DISCERN website.17
The medical staff and parentscarers (to be referred
to as ‘patients’ in this paper for the sake of simplicity)
then assessed the pamphlets using the Japanese
translation of DISCERN.
EVALUATION OF ENGLISH AND JAPANESE
WEBSITES ON ATOPIC DERMATITIS
To select potential websites for our study, we per-
formed a search of Japanese language websites using
a number of search engines (MSN, Yahoo, Nifty, Ly-
cos, Google, Altavista, Fresheye, Excite, Infoseek,
Goo and Infonav Japan) using the search term ‘atopic
dermatitis treatment’ in Japanese. We then hand
searched the first two hundred results yielded by
each search engine for suitable websites. We se-
lected twenty websites in total, ten in English lan-
guage and ten in Japanese language. Some websites
contained large quantities of up-to-date information
on treatments for which there is a good level of evi-
dence, and some of which contained little information
or which focused on treatments for which there is lit-
tle evidence. In doing so we aimed to select websites
spanning a wide spectrum of quality and reliability, so
as to make a wide range of scores more likely when
the websites were assessed using DISCERN.
Two raters evaluated the English language web-
sites and three raters evaluated the Japanese lan-
guage websites using the DISCERN instrument. All




Weighted kappa is the statistical method used most
often in assessing inter-rater agreement, including
previous studies involving DISCERN.11 We therefore
initially performed weighted kappa analysis of our re-
sults to allow comparison with the results of previous
studies. Analyses were performed on the total DIS-
CERN scores given to the pamphlets by both health
professionals and patients.
Websites
For each rater, the websites were ranked according
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Table 1 DISCERN scores given by health professionals and 




















to the DISCERN scores given by the rater. These
rankings were then compared using Kendall’s W for
the three raters of Japanese websites and using
Spearman rank correlation for the two raters of Eng-
lish websites.
RESULTS
The DISCERN scores given to the two pamphlets by
health professionals (HP) and patients (P) are sum-
marised in Table 1. These DISCERN scores were
used for the statistical analyses outlined above.
ASTHMA LEAFLET
For the pamphlet on asthma treatments, individual
kappa values for the health professionals group
ranged from −0.08 to 0.51 (average 0.15, 95% CI 0.13
to 0.18). For patients, the kappa values for individual
raters ranged from −0.26 to 0.46 (average 0.08, 95% CI
0.02 to 0.13).
ATOPIC DERMATITIS LEAFLET
Inter-rater variability for the health professionals
group and the patient group when rating the pam-
phlet on atopic dermatitis treatments was measured
using weighted kappa scores. The kappa values for
individual raters ranged from 0.21 to 0.44, with an av-
erage kappa score of 0.11 (95% CI 0.07 to 0.14). For
patients, the kappa values for individual raters ranged
from −0.03 to 0.39, average kappa score 0.16 (95% CI
0.12 to 0.20).
ATOPIC DERMATITIS WEBSITES
The DISCERN scores given by the four health profes-
sionals to the ten English language websites and ten
Japanese language websites are summarised in Table
2.
Comparison of the 3 raters’ DISCERN scores for
the ten Japanese language websites gave a Kendall W
score of 0.895 (p < 0.01). Comparison of the 2 raters’
DISCERN scores for the ten English language web-
sites gave a Spearman rank correlation score of 0.894
(p < 0.01).
DISCUSSION
FINDINGS OF PREVIOUS STUDIES
The results of the original DISCERN study gave
kappa values ranging from 0.23 to 0.70 for members
of an expert panel; from 0.13 to 0.63 for information
providers and 0.15 to 0.50 for patients.11 Kappa values
for the DISCERN question relating to the overall
quality of the information source were 0.53, 0.40 and
0.23 for these groups respectively. In other words,
when assessing the overall quality of the information
courses, there was a good level of agreement be-
tween experts and information providers, but only
reasonable agreement between patients. However,
there were higher levels of agreement between ques-
tions relating to more objective information reliability
criteria. The authors stated that with training, the
agreement between patients would be likely to im-
prove, and to meet this need they have provided
training sessions on how to use the instrument. The
authors also stated that the patients involved in pilot-
ing the instrument became more inclined to question
their assumption that some information is better than
none. In conclusion, the authors stated that DIS-
CERN could provide a framework for production,
evaluation and screening of health information and
enable patients to make informed treatment decisions
based on good evidence.
MAIN FINDINGS OF THIS STUDY
Our study revealed a wide range of kappa values
when comparing different raters’ DISCERN scores
for pamphlets on asthma and atopic dermatitis. This
reflects the tendency for specific raters to be harsher
or more generous in their scoring, which is of course
a well-known phenomenon (hence the need for sev-
eral independent judges at a competition). Generally,
the kappa values revealed a greater degree of inter-
rater agreement between health professionals than
between patients.
When health professionals used DISCERN to rate
and then rank websites on atopic dermatitis treat-
ments in our study, the final rankings given were
very consistent between different raters, as shown by
the high Kendall W and Spearman rank correlation
scores. In other words, when presented with a set of
websites, it would appear that DISCERN enables a
health professional to rank the websites consistently
in terms of their reliability. This is even without for-
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Table 2 DISCERN scores given by four health professionals to ten English language websites and ten Japanese language 
websites on treatments for eczema










mal training on how to use DISCERN.
WHAT THE RESULTS MEAN
Our study shows that DISCERN might not be as use-
ful as has been suggested previously for evaluating
the absolute reliability of medical information (owing
to low inter-rater agreement). An important new find-
ing is that DISCERN may be a useful means of find-
ing more reliable medical information through the
process of ranking of information sources (owing to
the greater inter-rater agreement when used to rank
these sources). Our study also confirms that DIS-
CERN seems to more effective when used by health
professionals, as demonstrated in previous studies.
The greater level of inter-rater agreement between
health professionals may be explained by the fact that
they are more familiar with the information they are
rating and so will be able to assess its reliability more
consistently. It is possible that there will be greater
agreement between patient raters if they are more fa-
miliar with the subject material or have received
training on how to use the DISCERN instrument, as
pointed out by the authors of the individual study al-
though it may not be feasible to provide patients with
such training. Of note, none of the participants in this
study (health professionals or patients) received for-
mal training on how to use DISCERN, but instead
they were issued with a brief summary on how to use
the instrument. It is quite possible that if all partici-
pants had received training on how to use DISCERN,
there may have been greater agreement between
their DISCERN scores.
Interestingly, the mean DISCERN scores for Eng-
lish language websites were higher than those for
Japanese language websites. There was also a wider
distribution of DISCERN scores for the Japanese
websites, implying that the quality of these websites
was highly varied. However, both sets of websites
were not selected randomly so no firm statements
about the reliability of English language websites
compared to Japanese language websites can be
made from these findings.
IMPLICATIONS FOR FUTURE RESEARCH
The question as to whether or not DISCERN also en-
ables patients to rate the reliability of websites consis-
tently should be the subject of further study. Internet
use is steadily increasing worldwide, and research
has shown that two-thirds of patients using the Inter-
net to access medical information think that this in-
formation is reliable.19 Griffiths and Christensen ex-
amined the potential of DISCERN as an indicator of
the quality of mental health websites when used by
patients.20 They found a good correlation between
evidence-based quality ratings and patients’ DIS-
CERN ratings, although only three patients were in-
cluded in the study. Clearly there is a need for larger-
scale studies of the potential of DISCERN in the
hands of patients.
CONCLUSION
In conclusion, our study provides evidence that DIS-
CERN may be of some use enabling both health pro-
fessionals and patients to assess the reliability of
medical information pamphlets, although the results
are more consistent when DISCERN is used by
health professionals. An important new finding in our
study was that DISCERN may also be useful in ena-
bling those with medical knowledge to rank medical
websites in terms of their reliability relative to each
other, although further studies would be needed to
show whether or not patients might be able to use
DISCERN in this way.
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